Home > News > Biophan Expands Biotechnology IP Portfolio to 114 Patents
March 29th, 2005
Biophan Expands Biotechnology IP Portfolio to 114 Patents
Abstract:
Biophan Technologies, Inc., a developer of next-generation biomedical technology, has announced continued growth of its intellectual property portfolio, reaching a total of 114 issued or filed patents in a range of cutting-edge biomedical fields. The newly-issued patents and recent patent applications claim important additional intellectual property coverage for the Company as it continues its development of advanced solutions for Magnetic Resonance Imaging (MRI) safety and image compatibility for surgical instruments and implanted devices, and other markets.
Source:
businesswire
Bookmark:
Announcements
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Patents/IP/Tech Transfer/Licensing
Nanoparticle Opens the Door to Clean-Energy Alternatives June 14th, 2013
DRYWIRED™ Receives MILITARY-STANDARD Certifications from QUANTA LABORATORIES for Its Latest Protective Nano-Coating Technology June 5th, 2013
Apple patents point to slimmer battery tech June 1st, 2013
Patent for Coaxial Nanofibre Production: Scientists from Contipro have patented new jet for effective coaxial nanofibers production May 31st, 2013